Screener
CONMED CNMD Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Revolving line of credit | $193,000 | — |
| Term A-1 Loan, net of deferred debt issuance costs of $168 and $218 in 2026 and 2025, respectively | 39,832 | 39,782 |
| Term A-2 Loan, net of deferred debt issuance costs of $3,474 in 2026 | 446,526 | — |
| 2.250% convertible notes, net of deferred debt issuance costs of $768 and $6,073 in 2026 and 2025, respectively | 153,990 | 793,927 |
| Finance leases | 901 | 1,233 |
| Total debt | 834,249 | 834,942 |
| Less: Current portion | 177,199 | 712 |
| Total long-term debt | $657,050 | $834,230 |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's long-term debt?
- CONMED (CNMD) reported long-term debt of $834.25M in Q2 2026.
- How has CONMED's long-term debt changed year-over-year?
- CONMED's long-term debt decreased by 5.4% year-over-year, from $881.83M to $834.25M.
- What is the long-term trend for CONMED's long-term debt?
- Over 5 years (2020 to 2025), CONMED's long-term debt has grown at a 2.1% compound annual growth rate (CAGR), from $753.64M to $834.94M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about CONMED's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude